Industry, FDA Coordination Key To Diagnostic Test Availability – McClellan
This article was originally published in The Gray Sheet
Executive Summary
FDA and CDC will coordinate efforts to provide standardized specimens of severe acute respiratory syndrome (SARS) to manufacturers by year-end to aid in validating diagnostics for the disease